↗
investz
Investing, A to Z
Markets
News
Research
Screener
Sectors
Learn
Watchlists
Portfolio
Books
Audio
☀
S&P 500 · SPY
759.97
▼ -3.99 (-0.52%)
DOW JONES · DIA
521.37
▼ -6.52 (-1.24%)
NASDAQ · QQQ
704.40
▼ -0.07 (-0.01%)
GOLD · GLD
$366.61
▼ -2.39 (-0.65%)
OIL (WTI) · USO
$169.53
▲ +7.02 (+4.32%)
BITCOIN
$80,339.63
▼ -430.04 (-0.53%)
--:--:--
NYSE · Live ET
AVBP (AVBP)
21.00
+1.80 (+9.38%)
USD · · delayed · updates about every minute
☆ Add to watchlist
Key statistics
Previous close
19.20
Day range
18.18 – 21.23
52-week low
11.36
52-week high
35.83
Volume
—
Type
—
52-WEEK RANGE POSITION
AVBP news
Quiver Quantitative
ArriVent BioPharma Reports 44.8% Objective Response Rate for ARR-217 in Late-Line Colorectal Cancer Patients
10h ago
Yahoo Finance Singapore
ArriVent BioPharma, Inc. (AVBP) stock price, news, quote and history
10h ago
Stock Titan
At one dose, an experimental cancer drug had a 44.8% response rate after earlier colorectal cancer treatments.
10h ago
Simply Wall Street
Is ArriVent BioPharma (AVBP) Fully Valued After The FURVENT Trial Miss And Legal Probe?
13h ago
Yahoo! Finance Canada
ArriVent BioPharma, Inc. (AVBP) Stock Price, News, Quote & History
17h ago
TradingView
ArriVent BioPharma, Inc. Estimates – NASDAQ:AVBP
1d ago
Yahoo Finance
Why ArriVent BioPharma Stock Is In Focus After Trial Failure And Legal Probe
1d ago
Simply Wall Street
ArriVent BioPharma Stock Is Up 9.4% What's Changed As ARR 217 Data Heads To ESMO
2d ago
Learn to invest
The Psychology of Money
Morgan Housel ·
Beginner
The Little Book of Common Sense Investing
John C. Bogle ·
Beginner
The Intelligent Investor
Benjamin Graham ·
Intermediate